Association between duration of phenoxybenzamine use and postoperative delirium in suspected adrenal pheochromocytoma: a retrospective cohort study

  • 0Department of Anesthesiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

|

|

Summary

This summary is machine-generated.

Prolonged phenoxybenzamine use increases the risk of postoperative delirium, particularly in patients without pheochromocytoma. This finding is independent of other risk factors, emphasizing appropriate drug duration for patient safety.

Area Of Science

  • Anesthesiology
  • Pharmacology
  • Surgical Oncology

Background

  • Limited evidence exists on the link between phenoxybenzamine duration and postoperative delirium in suspected adrenal pheochromocytoma.
  • Phenoxybenzamine is a critical medication for managing pheochromocytoma, but its optimal duration requires further investigation regarding patient outcomes.

Purpose Of The Study

  • To investigate the association between phenoxybenzamine use duration and the incidence of postoperative delirium.
  • To explore potential interactions between phenoxybenzamine duration and other variables influencing postoperative delirium.

Main Methods

  • Retrospective cohort study of 527 patients with suspected pheochromocytoma.
  • Data collected included CT characteristics, preoperative preparation, intraoperative details, and outcomes.
  • Logistic regression and interaction effect analyses were employed.

Main Results

  • Postoperative delirium occurred in 20.5% of participants (18.0% in pheochromocytoma group, 22.0% in non-pheochromocytoma group).
  • Increased phenoxybenzamine duration was positively associated with a higher risk of postoperative delirium (OR=1.05, p<0.01).
  • An interaction effect was observed, indicating the relationship between phenoxybenzamine duration and delirium varied based on pheochromocytoma status (p<0.05).

Conclusions

  • Inappropriate phenoxybenzamine duration is an independent risk factor for postoperative delirium.
  • The risk of delirium increases with longer phenoxybenzamine use, especially in patients without pheochromocytoma.
  • Optimizing phenoxybenzamine treatment duration is crucial for reducing postoperative delirium incidence.

Related Concept Videos

Adrenal Gland Disorders 01:27

1.3K

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...

Anxiolytic Drugs: Benzodiazepines and Buspirone 01:29

523

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...

Drugs Affecting Neurotransmitter Release or Uptake 01:21

952

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...

Stages of General Anesthesia 01:22

373

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...

Adrenergic Agonists: Therapeutic Uses 01:30

731

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance 01:23

84

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...